Sky Bio-Pharma (India ) Limited
About Sky Bio-Pharma (India ) Limited
Data last updated:
Sky Bio-Pharma (India ) Limited was a public limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 15 January 2002.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2002PLC134562. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It was led by directors including Vijay Chunilal Vyas and Vinod Somalal Vyas.
Its last annual general meeting (AGM) was held on 29 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 101 Ketan Apartments233 R B Mehta Marg Patel Chowk Ghatkopar (E), Mumbai, Maharashtra, India – 400077.
As per the financials filed for FY 2017, the company reported a revenue of ₹14.24 Lakh, a decline of 90% compared to the previous year. For the same year it recorded a net profit of ₹7.18 Lakh (net margin 50.4%) and EBITDA of ₹7.7 Lakh (EBITDA margin 54%).
Court records list 1 case involving the company, including 1 filed by the company.
Company details
Contact details
Sky Bio-Pharma (India ) Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address101 Ketan Apartments233 R B Mehta Marg Patel Chowk Ghatkopar (E), Mumbai, Maharashtra, India – 400077
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Sky Bio-Pharma (India ) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sky Bio-Pharma (India ) Limited
FY 2017 filings availableSky Bio-Pharma (India ) Limited reported revenue of ₹14.24 Lakh (down 90% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 90% in the latest year. EBITDA fell 94% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹7.7 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹7.18 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 54% | ||
| Net Profit Margin | 50.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sky Bio-Pharma (India ) Limited, buy the company report.
Board of directors of Sky Bio-Pharma (India ) Limited
Sky Bio-Pharma (India ) has 8 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Chunilal Vyas | Director | 16 Mar 2015 | 11 Years 7 Months | As last reported |
| Vinod Somalal Vyas Also directs: Veedol Corporation Limited, Standard Greases and Technologies Private Limited, Tarapur Grease Industries Private Limited and 5 more | Director | 15 Jan 2002 | 24 Years 9 Months | As last reported |
| Haresh Somalal Vyas | Director | 15 Jan 2002 | 24 Years 9 Months | As last reported |
| Bharat Chunilal Vyas | Director | 16 Mar 2015 | 11 Years 7 Months | As last reported |
| Dhruv Somalal Vyas | Director | 16 Mar 2015 | 11 Years 7 Months | As last reported |
| Durgesh Sanjivrao Chandavarkar Also directs: Veedol Corporation Limited, Standard Greases and Technologies Private Limited, Tarapur Grease Industries Private Limited and 5 more | Director | 15 Jan 2002 | 24 Years 9 Months | As last reported |
Peer comparison
Sky Bio-Pharma (India ) Limited is compared with the 10 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Base Metal Chemicals Pvt Ltd | ₹14.46 Lakh (FY 2025) | 4.0% | Vadodara, Gujarat, India | |||
| Vavik Industries Private Limited | ₹14.38 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Ultra Pure Rasayan Private Limited | ₹14.37 Lakh (FY 2024) | 140.0% | Thane, Maharashtra, India | |||
| Kanchan Carbonates Private Ltd | ₹14.35 Lakh (FY 2017) | -62.0% | Delhi, India | |||
| Dacl Fine Chem Limited | ₹14.28 Lakh (FY 2025) | 178.0% | Vadodara, Gujarat, India | |||
| Sky Bio-Pharma (India ) Limitedthis company | ₹14.24 Lakh (FY 2017) | ₹7.18 Lakh | 50.4% | -90.0% | Mumbai, Maharashtra, India | |
| Sygnific Agro Sciences Private Limited | ₹14.14 Lakh (FY 2021) | Kolkata, West Bengal, India | ||||
| Vivira Chemicals Pvt Ltd | ₹14.11 Lakh (FY 2020) | 7.0% | Navi Mumbai, Maharashtra, India | |||
| Maklin Orgamics Private Limited | ₹14.11 Lakh (FY 2024) | -40.0% | Bellary, Karnataka, India | |||
| Goldfarm Chemical Company Private Limited | ₹14.1 Lakh (FY 2016) | -98.0% | Mumbai, Maharashtra, India | |||
| Crystal Sleeves Mfg Private Limited | ₹14.05 Lakh (FY 2025) | 14.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sky Bio-Pharma (India ) Limited, buy the company report.
Auditor
Sky Bio-Pharma (India ) Limited is audited by K V Bhat & Co for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K V Bhat & Co | FY 2016 |
Shareholding
The shareholding of Sky Bio-Pharma (India ) Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sky Bio-Pharma (India ) Limited, buy the company report.
Legal cases
Sky Bio-Pharma (India ) Limited has 1 court case on record: 1 filed by Sky Bio-Pharma (India ). All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (SS) | Filed by the company against Pradeep Shetye Pvt. Ltd. | Disposed |
To see the full case history of Sky Bio-Pharma (India ) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sky Bio-Pharma (India ) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sky Bio-Pharma (India ) has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sky Bio-Pharma (India ) Limited, buy the company report.
Recent activity
Sky Bio-Pharma (India ) Limited has 11 board changes on record since 2002: 8 appointments and 3 cessations. The latest: Bharat Chunilal Vyas ceased to be Additional Director on 30 Sep 2016.
2 earlier events are in the company report.
Frequently asked questions
Sky Bio-Pharma (India ) has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Sky Bio-Pharma (India ) was a public limited company based in Mumbai, Maharashtra, India. The company worked in industrial chemicals, within the chemicals and materials industry. It was incorporated on 15 January 2002 and is registered under CIN U24110MH2002PLC134562. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Sky Bio-Pharma (India ) was incorporated on 15 January 2002. It is registered with the Registrar of Companies, Mumbai.
Sky Bio-Pharma (India ) had 8 directors:
- Vijay Chunilal Vyas - Director
- Vinod Somalal Vyas - Director
- Haresh Somalal Vyas - Director
- Bharat Chunilal Vyas - Director
- Dhruv Somalal Vyas - Director
- Durgesh Sanjivrao Chandavarkar - Director
- Jitendra Garganarayan Goswami - Director
- Ketan Vinod Vyas - Director
The CIN (Corporate Identification Number) of Sky Bio-Pharma (India ) is U24110MH2002PLC134562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sky Bio-Pharma (India ) is at 101 Ketan Apartments233 R B Mehta Marg Patel Chowk Ghatkopar E, Mumbai, Maharashtra, India – 400077.
The latest financial statements of Sky Bio-Pharma (India ) on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 29 September 2017. Year-wise statements from 2015 are in the company report.
No. Sky Bio-Pharma (India ) has 2 GST registrations on record and all of them are cancelled or inactive.
Sky Bio-Pharma (India ) operated in the chemicals and materials industry, in the industrial chemicals segment.
The peers of Sky Bio-Pharma (India ) by revenue are Base Metal Chemicals Pvt Ltd, Vavik Industries Private Limited, Ultra Pure Rasayan Private Limited, Kanchan Carbonates Private Ltd, Dacl Fine Chem Limited and 5 more, all in the Chemicals industry (Industrial Chemicals).
Sky Bio-Pharma (India ) has 1 court case on record: 1 filed by the company.